Osteoarthropathy is a broad medical term for any disease affecting both bones and joints. In practice, when doctors use this word, they almost always mean hypertrophic osteoarthropathy (HOA), a syndrome defined by three hallmark features: clubbing of the fingers or toes, painful joints, and new bone growth along the shafts of long bones. It can appear on its own as a rare genetic condition or, more commonly, as a signal that something else is going on in the body, particularly in the lungs.
Primary vs. Secondary Forms
Hypertrophic osteoarthropathy comes in two distinct forms. The primary form, called pachydermoperiostosis, is a genetic condition with a prevalence of less than 1 in a million. It typically appears in childhood and is caused by mutations in the HPGD gene, which encodes an enzyme responsible for breaking down prostaglandins. When that enzyme doesn’t work properly, prostaglandin levels stay chronically elevated, driving inflammation, bone changes, and tissue overgrowth. It can be inherited from both parents (autosomal recessive), though carriers with only one copy of the mutation sometimes develop a milder version.
The secondary form is far more common and develops as a response to an underlying disease. Lung cancer is the most well-known trigger. Roughly 5% of people with lung cancer develop hypertrophic osteoarthropathy as a paraneoplastic syndrome, meaning the cancer indirectly causes it through chemical signals rather than by spreading to the bones. Other conditions linked to secondary HOA include cystic fibrosis, cyanotic heart disease, and chronic lung infections, essentially any condition that causes low blood oxygen levels or disrupts normal blood flow through the lungs.
What Happens Inside the Body
The underlying mechanism involves growth factors that normally help build blood vessels and repair tissue being released in abnormal amounts. When a tumor secretes these factors, or when low oxygen triggers their production, they flood the bloodstream and reach the bones, joints, and soft tissues of the extremities. These growth factors stimulate the formation of new, immature blood vessels whose walls are unusually leaky. The result is swelling, fluid buildup in joints, and the deposit of new bone along the outer surface of existing bones.
There’s also a mechanical explanation. Normally, platelet precursors traveling through the lungs get broken into smaller fragments before entering general circulation. In people with lung shunts or certain heart defects, those large precursors bypass the lungs entirely. When they get trapped in small blood vessels in the hands, feet, and long bones, they release growth factors locally, promoting excessive tissue growth and vascular changes at those sites. When the underlying cause is a tumor, surgically removing it leads to a measurable drop in these circulating growth factors, and symptoms often improve.
How It Looks and Feels
The most visible sign is digital clubbing, where the fingertips or toes become rounded and bulbous and the nails curve over the tips. This happens gradually and is sometimes the first thing a person or their doctor notices. Joint pain tends to concentrate in the lower limbs, particularly the knees, ankles, and wrists, and can range from mild achiness to significant discomfort with visible swelling. Some people have no symptoms at all and are diagnosed only when imaging is done for another reason.
In the primary (genetic) form, skin changes are prominent. The skin of the face and scalp thickens noticeably, a feature called pachyderma, which can coarsen facial features and cause the eyelids to droop. Excessive sweating of the palms and soles is common, along with oily skin and seborrheic dermatitis. Over time, the hands and feet may enlarge, joints can stiffen, and some patients develop severe curvature of the spine. Neurological symptoms can also occur.
How It’s Diagnosed
Diagnosis relies on a combination of physical examination and imaging. X-rays of the long bones reveal periosteal thickening, meaning a layer of new bone forming along the shafts of the femur, tibia, and fibula. This bilateral, symmetrical pattern of bone growth is the hallmark radiological finding. A bone scan (radionuclide scintigraphy) shows a characteristic “double stripe” sign, also called the tramline or parallel tract sign, where tracer uptake lights up along both sides of the bone’s cortex.
The key diagnostic step is distinguishing HOA from conditions that mimic it. Thyroid acropachy, vascular insufficiency, and pachydermoperiostosis itself can all produce similar periosteal reactions on X-ray. If there’s no known family history or genetic mutation, the workup shifts toward finding an underlying cause, often starting with chest imaging to look for lung masses, infections, or structural heart problems.
Treatment and Symptom Management
For secondary HOA, treating the underlying condition is the most effective strategy. When a lung tumor is the cause, removing it often resolves the joint pain and can halt or reverse the bone changes. Clubbing may also improve over time, though it doesn’t always fully resolve.
For symptom relief, anti-inflammatory medications are the first-line approach. These work by blocking the production of prostaglandins, the same inflammatory molecules that drive much of the syndrome’s tissue changes. Bisphosphonates, drugs more commonly used for osteoporosis, have also shown benefit for the bone pain associated with HOA. However, there’s evidence that taking anti-inflammatory drugs alongside bisphosphonates may blunt the bone-protective effects of the bisphosphonate, so these medications may need to be managed carefully when used together.
In the primary genetic form, where there’s no underlying disease to treat, management focuses on controlling symptoms long-term. Joint pain, skin thickening, and excessive sweating are addressed individually, and the condition can leave people with chronic complications like persistent clubbing and arthritis that limit daily function.